The World Health Organization has approved a second Chinese COVID-19 vaccine for emergency use in adults aged 18 and over. Sinovac's Coronavac is the eighth vaccine to win a WHO listing to combat the virus. Graeme Smith, a fellow at the Australian National University's Pacific Affairs Department, tells The World while its efficacy is as low as 51 per cent, the vaccine is still good enough to be part of the Covax program.

Subscribe: [ Ссылка ]

ABC News provides around the clock coverage of news events as they break in Australia and abroad, including the latest coronavirus pandemic updates. It's news when you want it, from Australia's most trusted news organisation.

For more from ABC News, click here: [ Ссылка ]
Watch more ABC News content ad-free on iview: [ Ссылка ]

Go deeper on our ABC News In-depth channel: [ Ссылка ]
Like ABC News on Facebook: [ Ссылка ]
Follow ABC News on Instagram: [ Ссылка ]
Follow ABC News on Twitter: [ Ссылка ]

#ABCNews #ABCNewsAustralia

свернуть